The stock market has been racing higher at nearly unprecedented levels in recent years. Even so, the healthcare sector in general, and biopharma stocks in particular, have still managed to crush the broader markets over the last few years. Since 2012, for instance, the iShares Nasdaq Biotech Index has more than tripled the returns of the closely watched S&P 500:Perhaps […]
Biotechnology stocks have been among the market’s top performers this year, with the iShares Nasdaq Biotechnology ETF’s 36% gain handily outpacing the S&P 500 ‘s 14% return. That heady return, however, comes with one potential drawback: It might be tough to figure out which biotech stocks will continue climbing next year. With that in mind, here are three large-cap biotech […]
Dividend paying stocks are a staple in market-beating investment portfolios, but dividend investors don’t have very many options when it comes to investing in the biotechnology sector. Out of the largest biotechnology stocks, only Amgen has made the decision to reward investors with dividend payments.That’s likely frustrating to dividend investors. After all, biotech stocks like Gilead Sciences generate billions of […]
Source: ;Flickr user VastateparksstaffWhen to sell a winning stock is one of the toughest questions for investors to answer. Selling a stock that is reaching for new highs might be the right decision sometimes, but other times it might mean getting out of a long-haul opportunity too early. With that in mind, we asked three Motley Fool analysts to tell […]
Continuing our “Intraday Trend Trading” stock scans according to an algorithm I run mid-day, let’s take a look not just at the strong intraday uptrending stocks, but also the four “worst” intraday downtrending stocks.Here’s the strong uptrenders on yet another uptrending session:Our “Top Four Intraday Trenders include WellPoint (WLP), Travelers Insurance (TRV), 3M Company (MMM), and Aetna (AET).Again, pro-trend traders […]
